Development of Novel ADC-Resistant Models
Antibody‒drug conjugates (ADCs), which combine the advantages of monoclonal antibodies with precise targeting and payloads, show great potential as cancer...
Continue Reading
Antibody‒drug conjugates (ADCs), which combine the advantages of monoclonal antibodies with precise targeting and payloads, show great potential as cancer...
Continue Reading
Gout is a common type of inflammatory arthritis caused by elevated uric acid levels in the blood. When uric acid...
Continue Reading
In our latest publication, WuXi AppTec scientists introduce two new methods that utilize readily accessible aldehydes to create substituted isoxazolines...
Continue Reading
From April 25 to 30, 2025, the annual meeting of the American Association for Cancer Research (AACR), one of the...
Continue Reading
At this year’s annual meeting of the American Association for Cancer Research (AACR), WuXi Biology has been selected to present...
Continue Reading
From Pathogenesis to Therapeutic Innovations Introduction: Membranous nephropathy (MN) has received particular attention among autoimmune kidney disease due to its...
Continue Reading
Systemic sclerosis (also known as scleroderma) is a chronic autoimmune disease that leads to the buildup of scar tissue in...
Continue Reading
Synthetic lethality, where combining two non-lethal mutations results in cell death, is exploited in cancer therapy, with PARP inhibitors like...
Continue Reading
Polycythemia vera (PV) is a chronic myeloproliferative disorder, a type of blood cancer characterized by the overproduction of red blood...
Continue Reading